1. Home
  2. KALV vs ITRN Comparison

KALV vs ITRN Comparison

Compare KALV & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$65.84

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
ITRN
Founded
N/A
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
KALV
ITRN
Price
$26.99
$65.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$32.60
$60.67
AVG Volume (30 Days)
3.0M
135.0K
Earning Date
07-09-2026
05-26-2026
Dividend Yield
N/A
3.61%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$12.38
Revenue Next Year
$59.23
$8.21
P/E Ratio
N/A
$16.85
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$32.71
52 Week High
$27.00
$68.30

Technical Indicators

Market Signals
Indicator
KALV
ITRN
Relative Strength Index (RSI) 75.79 66.61
Support Level $14.22 $55.33
Resistance Level N/A $68.30
Average True Range (ATR) 0.03 2.82
MACD -0.23 -0.11
Stochastic Oscillator 95.83 77.93

Price Performance

Historical Comparison
KALV
ITRN

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

Share on Social Networks: